Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...

Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

No one has ever known so much about healthy eating and been less successful at following her own advice.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...